Replimune Group, Inc. cash flow to debt ratio of -251.24% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Replimune Group, Inc.'s free cash flow has decreased 43.04% from $-198.94M last year to $-284.57M, signaling decreasing performance

Replimune Group, Inc.'s debt to equity ratio is 0.67, which means that the company's assets are unhealthy financed, signaling financial risk.

Replimune Group, Inc.'s debt has increased relative to shareholder equity from 0.18 last year to 0.67 today, signaling weakened financials

Replimune Group, Inc. has a net cash position, so leverage is healthy.

Replimune Group, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Replimune Group, Inc. has insufficient data to evaluate this check.

Replimune Group, Inc.'s short-term assets of $279.12M exceed its short-term liabilities of $58.23M

Replimune Group, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Replimune Group, Inc.'s return on equity of -128.57%, is lower than 15.00%, indicating bad performance

Replimune Group, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Replimune Group, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Replimune Group, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Replimune Group, Inc. has negative free cash flow, indicating cash burn

Replimune Group, Inc.'s yearly earnings has decreased 26.95% since last year from $-247.30M to $-313.94M, signaling decreasing performance

Replimune Group, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -114.79% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Replimune Group, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Replimune Group, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Replimune Group, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Replimune Group, Inc. has insufficient data to evaluate this check.

Replimune Group, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Replimune Group, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Replimune Group, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Replimune Group, Inc. has insufficient data to evaluate this check.

Replimune Group, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Replimune Group, Inc. has a price-to-book ratio of 7.64x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Replimune Group, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue